Dorman Products, Inc. Reports Third Quarter 2026 Results; Updates 2026 Guidance
Source: globenewswire.com

Dorman Products reported Q3 2026 sales of $561.7 million, up 3.3% year over year, while diluted EPS fell 20% to $1.98 and adjusted EPS declined 21% to $2.08. Gross margin contracted to 39.4% from 44.4%; the company attributed the earnings comparison partly to tariff-related pricing that benefited Q3 2025. Dorman narrowed 2026 sales-growth guidance to 2%–3% from 3%–5% and adjusted EPS guidance to $8.50–$8.70 from $8.50–$8.80; it generated $64.6 million in operating cash flow and repurchased $15 million of shares in the quarter.
Analysis
The key signal is not the modest sales outlook reset; it is the sharp deterioration in gross margin despite growth across segments. That points to tariff/pricing lag, cost mix, or both—not simply weak demand—and makes the planned Q4 pricing actions the critical test. If increases stick without volume or customer-retention damage, margins can recover; if not, the market may need to reset its view of Dorman’s pricing power. Heavy Duty’s reported segment profit margin at zero is a separate warning: investigate whether this is temporary cost absorption or a structural profitability problem before treating broad aftermarket demand as the explanation.
The near-term catalyst is the October 27 call. Seek quantification of tariff exposure by sourcing region, the timing and customer acceptance of price increases, and a segment bridge for margins. Over 1–3 months, monitor gross-margin recovery and sales volumes; over 6–18 months, sustained tariff pass-through and product wins matter more than headline growth. The contrarian angle: EPS guidance barely moved at the midpoint, which may reassure investors, but that masks the margin reset and depends on future pricing actions. Conversely, the tariff-related comparison makes the year-over-year EPS decline a poor standalone measure of underlying demand. Buybacks and cash generation provide support, but do not establish that operating margins have bottomed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.32
Ticker Sentiment
Key Decisions for Investors
- Keep DORM underweight / avoid buying the initial dip until the call clarifies the gross-margin bridge and evidence of customer acceptance for Q4 pricing. The thesis is falsified by clear sequential margin recovery with stable volumes and no further guidance pressure.
- For a defined-risk bearish expression, consider a short-dated put spread only after the call if management cannot quantify pass-through timing or explains continued Heavy Duty losses; avoid an unhedged short based solely on the year-over-year EPS comparison.
- Track quarterly gross margin, Heavy Duty segment profitability, and sales-volume effects from pricing. A second margin decline or another reduction in adjusted EPS guidance would strengthen the negative view; sustained margin stabilization would weaken it.
- Reconcile operating cash flow with working-capital movements before assigning it a recurring valuation premium: inventory has fallen materially from year-end while receivables have risen, so cash conversion may not be a clean proxy for earnings quality.
More News
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- EQT becomes the nation’s leading natural gas ‘juggernaut’ with a $13B deal as data center, export demand surges
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Anthropic’s risk factors include the end of humanity, a feud with the Pentagon, and CEO Dario Amodei’s reputation
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis
- Why is PagSeguro Digital stock plummeting 30% today?